Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy-Reference-Cited by-同舟云学术

Open‐label long‐term treatment of add‐on triheptanoin in adults with drug‐resistant epilepsy

Author:

Borges Karin¹^ORCID,Kaul Neha²³⁴,Germaine Jack⁴,Carrasco‐Pozo Catalina⁵,Kwan Patrick³⁴,O’Brien Terence J.³⁴

Affiliation:

1. School of Biomedical Sciences Faculty of Medicine The University of Queensland St. Lucia QLD Australia

2. Department of Allied Health (Clinical Nutrition) Royal Melbourne Hospital University of Melbourne Parkville Vic Australia

3. Departments of Medicine and Neurology Royal Melbourne Hospital University of Melbourne Parkville Vic Australia

4. Departments of Neuroscience and Neurology The Central Clinical School Monash University and The Alfred Hospital Melbourne Vic Australia

5. Discovery Biology Griffith Institute for Drug Discovery Griffith University Nathan QLD Australia

Funder

Ultragenyx Pharmaceutical

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

Reference33 articles.

3. PET studies in epilepsy;Sarikaya I;Am J Nucl Med Mol Imaging,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Triheptanoin as a nutraceutical and its potential use in epilepsy;Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders;2023

3. Triheptanoin in Epilepsy and Beyond;Ketogenic Diet and Metabolic Therapies;2022-04